Literature DB >> 6467212

Sodium butyrate induction of milk-related antigens in human MCF-7 breast carcinoma cells.

M Abe, D W Kufe.   

Abstract

We have monitored the effects of sodium butyrate on expression of a human breast tumor-associated antigen defined by a murine monoclonal antibody designated DF3. This cell surface antigen has a molecular weight of approximately 300,000 and is related to a higher-molecular-weight antigen detectable in human milk. The results demonstrate that butyrate increases the membrane expression of the DF3 tumor-associated antigen. Further, butyrate treatment specifically enhances production of the DF3-related milk antigen. These effects occur at butyrate concentrations lower than that required for maximal expression of carcinoembryonic antigen and occur in the absence of changes in the expression of nonspecific cross-reacting antigen. The results suggest that butyrate induces a more differentiated MCF-7 phenotype and that this model may be useful in studying maturation of human breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467212

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.

Authors:  N Ohuchi; S Sato; M Akimoto; Y Taira; N Matoba; K Takahashi; S Mori
Journal:  Jpn J Surg       Date:  1991-03

2.  Human tumor and normal tissue reactivity of the anti-(breast cancer) monoclonal antibody BA-Br-3 and its similarity to the anti-(epithelial membrane antigen) monoclonal antibody E29.

Authors:  S K Liao; R E Flahart; B Kimbro; L Horton; R K Oldham; J Hilgers; R van der Gaag
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Effect of hyperosmolality on alkaline phosphatase and stress-response protein 27 of MCF-7 breast cancer cells.

Authors:  M Kato; D Brijlall; S A Adler; S Kato; F Herz
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene.

Authors:  M Abe; D Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

5.  Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.

Authors:  J Siddiqui; M Abe; D Hayes; E Shani; E Yunis; D Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.

Authors:  J Lundy; A Thor; R Maenza; J Schlom; F Forouhar; M Testa; D Kufe
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.

Authors:  D F Hayes; H Sekine; T Ohno; M Abe; K Keefe; D W Kufe
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Study of the biological and prognostic significance of the antigen CaMBr8 on breast carcinoma.

Authors:  P Facheris; F Perrone; S Ménard; S Andreola; P Bazzini; R Bufalino; S Canevari; N Cascinelli; E Colzani; G Di Fronzo
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.